Lineage Cell Therapeutics, Inc. Announces Appointment of Anula Jayasuriya to its Board of Directors
May 05, 2021 at 06:00 am EDT
Lineage Cell Therapeutics, Inc. announced the appointment of Anula Jayasuriya, M.D., Ph.D., M.B.A., to the Company’s Board of Directors, effective May 4, 2021. Dr. Jayasuriya is a successful healthcare private equity executive and venture capitalist with extensive clinical, industry, entrepreneurial, and investment experience. Dr. Jayasuriya is the Founder & Managing Director of EXXclaim Capital, an early-stage venture fund focused on catalyzing innovation, entrepreneurship and investment in Women’s Health, and a Co-founder of Evolvence India Life Science Fund (EILSF), the first fund in India to focus exclusively on healthcare and invest in Indian pharmaceutical, biotechnology, medical device and contract services companies.